Tanzania’s Dr Faustine Ndugulile has been nominated as the next Regional Director for the World Health Organization (WHO) African Region, defeating more experienced WHO insiders in a closely contested race. Ndugulile secured 25 of the 46 votes at the WHO Africa regional conference in the Republic of Congo, defeating Dr Ibrahima Socé Fall (proposed by […] Continue reading ->
The World Health Organization (WHO) will decide on whether to issue an emergency use listing (EUL) for an mpox vaccine within three weeks after its manufacturer supplied the global body with all the required information last Friday, Director-General Dr Tedros Adhanom Ghebreyesus told the opening of the WHO Africa regional conference on Monday. The WHO […] Continue reading ->
Bavarian Nordic has no plans to sell or manufacture its vaccines directly to African countries, the company’s Vice President of Investor Relations told Health Policy Watch, saying that donations from rich countries will likely be the main source of supplies.   WHO’s announcement of a global mpox health emergency may have sent a wake-up call to […] Continue reading ->
The recent CARICOM summit of Caribbean leaders has endorsed a new Afro-Caribbean Health and Development  (HeDPAC) initiative aimed at stimulating South-South collaboration on resilient health systems, health worker capacity building, and local medicines and vaccines manufacture.  The formal CARICOM Communiqué at the close of the Summit in Grenada invited its 15 member states and five […] Continue reading ->
“Words must now be matched with deeds,” Africa CDC Director General Jean Kaseya said after the official declaration. The Africa Centers for Disease Control and Prevention (Africa CDC) has officially declared the surging mpox outbreak a “public health emergency of continental security” – the first time it has made such a declaration on its own. […] Continue reading ->
The Argentina-based biotech firm,  Sinergium Biotech, has agreed to share know-how on the production of an mRNA vaccine for Avian influenza (H5N1) with WHO’s  Tecnology Transfer Hub so that an affordable vaccine could rapidly be produced for developing countries, WHO said Monday. The agreement marks the first time that a vaccine developer has actually volunteered […] Continue reading ->